ARCHES contributes to the fight against the COVID-19 pandemic
The world is facing a major public health crisis in the form of COVID-19. There is a lot to know and unravel about the pathophysiology, natural course and treatment of this disease. Mortality is variable, however, elderly people with diabetes and hypertension - the two main components of metabolic syndrome - seem to have severe disease outcomes. To actively contribute to the fight against the COVID-19 pandemic, ARCHES has relaunched its research programme for the prevention and management of metabolic syndrome with a specific focus son immunosenescence, which unfortunately conditions the clinical course of the pandemic in the elderly.